United Therapeutics (UTHR) Net Margin Growth (3y) (2012 - 2026)
United Therapeutics (UTHR) Net Margin Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 1,620.00 |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | -98.00 |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | -4,358.00 |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | -1,235.00 |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | -100.00 |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 4,252.00 |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | -404.00 |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn | 2,318.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,235.00 |
| Dec 31, 2025 | 1,923.00 |
| Sep 30, 2025 | -401.00 |
| Jun 30, 2025 | 1,391.00 |
| Mar 31, 2025 | -1,138.00 |
| Dec 31, 2024 | 1,392.00 |
| Sep 30, 2024 | 469.00 |
| Jun 30, 2024 | 24.00 |
| Mar 31, 2024 | 3,778.00 |
| Dec 31, 2023 | 965.00 |
| Sep 30, 2023 | -113.00 |
| Jun 30, 2023 | 1,387.00 |
| Mar 31, 2023 | 888.00 |
| Dec 31, 2022 | 997.00 |
| Sep 30, 2022 | 1,340.00 |
| Jun 30, 2022 | -3,005.00 |
| Mar 31, 2022 | 18,834.00 |
| Dec 31, 2021 | 990.00 |
| Sep 30, 2021 | 1,078.00 |
| Jun 30, 2021 | -24.00 |